Suzette Heptinstall
Adult Health · Baltimore, MDNPI 1336307073
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 36 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,289, 6.4 times the $202 reported in 2021.
Across 36 payments — averaging $110.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$580
- Teva Pharmaceuticals USA, Inc.$372
- Novo Nordisk$366
- AbbVie$238
- Johnson & Johnson$227
- Dexcom, Inc.$214
- plus $2K from 17 others
What the payments were for
- Food & beverage$3,993100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 5 | $580 |
| Teva Pharmaceuticals USA, Inc. | 3 | $372 |
| Novo Nordisk | 3 | $366 |
| AbbVie | 2 | $238 |
| Johnson & Johnson(2 entities) | 2 | $227 |
| Dexcom, Inc. | 2 | $214 |
| Idorsia Pharmaceuticals US Inc | 2 | $211 |
| Vertex | 2 | $167 |
| EMD Serono, Inc. | 1 | $138 |
| Amgen | 1 | $125 |
| Phathom Pharmaceuticals, Inc. | 1 | $123 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $121 |
| Amarin Pharma, Inc. | 1 | $120 |
| Hologic Sales And Service, LLC | 1 | $119 |
| Ultragenyx Pharmaceutical Inc. | 1 | $118 |
| Vertos Medical, Inc. | 1 | $117 |
| Sanofi-aventis U.S. LLC | 1 | $111 |
| Nestle Healthcare Nutrition Inc. | 1 | $110 |
| Bayer | 1 | $107 |
| Sage Therapeutics, LLC | 1 | $99 |
| Aimmune Therapeutics, Inc. | 1 | $86 |
| Coloplast | 1 | $76 |
| Solventum Corporation | 1 | $47 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,993 in reported general payments places this provider in the 85th percentile of 542 adult health providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Naloxone Hcl | 21 | $1,378 |
| Oxycodone Hcl | 54 | $211 |
| Gabapentin | 12 | $199 |
| Pantoprazole Sodium | 20 | $156 |
| Methocarbamol | 16 | $89 |
Paid to pharmacies, not to this prescriber.
Other adult health in Baltimore
- Christopher RobersonBaltimore$180K
- Amit DhirBaltimore$97K
- Brendon BowerBaltimore$64K
- Caitlin NassBaltimore$46K
- Sarah RileyBaltimore$24K
- Monica LovinsBaltimore$18K
- Elizabeth ChandlerBaltimore$17K
- Clifton DawsonBaltimore$14K
- Selina YeasminBaltimore$8K
- Andrea ArroyoBaltimore$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.